2021

Cancer Week: Όλες οι εξελίξεις γύρω από τον καρκίνο.

Με τη δέσμευση της ηγεσίας των Υπουργείων Ελλάδας και Κύπρου ότι θα στηρίξουν την πρόληψη, την πρόσβαση σε νέες θεραπείες και την ανάπτυξη των κλινικών μελετών για τον καρκίνο, ολοκληρώθηκε μια πλήρης συνεδριακή ψηφιακή εβδομάδα για τον καρκίνο, το Cancer Week 2021, που διοργανώθηκε από το Health Daily και τη BOUSSIAS, από τις 18-22 Οκτωβρίου. Στις πέντε ημέρες του συνεδρίου 94 εξέχοντες επιστήμονες από τον διεθνή, ελληνικό και κυπριακό χώρο, εκπρόσωποι της ιατρικής κοινότητας, του ακαδημαϊκού και ερευνητικού χώρου, εκπρόσωποι των υπουργείων, δημοσίων και ιδιωτικών φορέων, εκπρόσωποι ασθενών, συνομίλησαν για τα πλέον επίκαιρα θέματα που αφορούν την πρόληψη και θεραπεία του καρκίνου. Το συνέδριο στέφθηκε με μεγάλη επιτυχία, ενώ τις εργασίες του παρακολούθησαν περισσότεροι από 550 σύνεδροι.


PRESENTATIONS 2021ΔΕΛΤΙΟ ΤΥΠΟΥ
2020

Cancer and Personalized Medicine Conference


PRESENTATIONS 2020

Cancer & Personalized Medicine Conference 2019

2019

Cancer and Personalized Medicine Conference

A Policy Debate on the Value & Cost of Treatment

Innovations in cancer therapy, particularly the development of targeted drugs and immunotherapies, hold remarkable potential to transform treatment of the disease. Increasingly, a new generation of cancer drugs is producing durable remissions and, potentially, cures. However, defining the value of cancer drugs is challenging. Numerous factors influence value, and the relative importance of each of these factors depends on the perspective of the stakeholders (patients, society, providers, payers, healthcare systems, manufacturers, researchers and academics). Though the needs of all stakeholders should be considered, patient benefit must be central when assessing value.


PRESENTATIONS 2019
2018

Cancer and Personalized Medicine Conference

Value has become a central topic in any debate regarding cancer care in Greece and abroad, for a simple reason: reality has caught up with us. Costs and treatment innovations are conflicting realities that force the oncology community to adopt value-based solutions to a system in crisis. On one side, the pace of innovation in oncology is tremendous and unprecedented: newly approved drugs abound; precision oncology and immunotherapy are gradually becoming a reality; and patients are having access to an increasing number of treatment options that help them live longer with better quality of life. On the other side, the costs to treat cancer are astronomical and continue to increase, threatening our own ability to provide cancer care and causing financial harm to patients.

PRESENTATIONS 2018

Cancer and Personalized Medicine Conference

2017

Cancer and Personalized Medicine Conference

Closing the Gap: Quality Cancer Treatment & Diagnosis for All

PRESENTATIONS 2017
2016

Cancer Policy & Economics Conference II


Cancer Policy & Economics Conference

2015

Cancer Policy & Economics Conference I

Ensuring Quality and Equality of Treatment

Cancer is not only the main therapeutic challenge of our society, being one of the most serious and fatal diseases worldwide, but also a great challenge for healthcare system sustainability, because of its significant economic burden on budgets of state and individuals.

In the coming decades, changes in cancer rates related to demographic shifts in EU are about to offset recent mortality reductions and result in a marked increase in the number of new cancer diagnoses made each year. In Greece as in EU, cancer is projected to become the nation’s leading cause of death over the next decade as the population ages. On the other hand, the research on cancer treatment and prevention has set the lights of pharmaceutical industry and academic society on it. The conference will focus on the adoption of strong policies at a national and international level, in order to exploring opportunities to significantly improve cancer patient outcomes by fostering innovative research approaches and intensifying cancer prevention research efforts, to reduce the economical burden targeted to this disease.


Χορηγίες – Συμμετοχές
Χρυσούλα Κορδούλη, Τ: +30 210 6617 777 (ext. 204), fax: +30 210 6617 778, E: [email protected]
Νίκος Τσάκωνας, M: +30 6936123475 , E: [email protected]
 
Χορηγίες – Συμμετοχές για Κύπρο
Συμμετοχές: Έλενα Χατζηνικολάου, T. (+357)  96494925, [email protected]
Χορηγίες: Γιώργος Λοϊζου, T.  (+357) 99 103323, E. [email protected]
 
Πληροφορίες
Ναταλία Τουμπανάκη, Τ: +30 210 6617 777 (ext. 289), F: 210 6617778, E: [email protected]
Νέλλη Καψή, Τ: 210 6617777 (εσωτ. 204), F: 210 6617778, E: [email protected]

BOUSSIAS

 Κλεισθένους 338, 15344, Γέρακας, Αττική, Ελλάδα
  +30 210 6617777
  +30 210 6617778
  www.boussias.com